Clinical efficacy of Liquid biopsy for acquired resistance to afatinib in EGFR positive NSCLC
Latest Information Update: 25 May 2021
At a glance
- Drugs Afatinib (Primary) ; Erlotinib; Gefitinib
- Indications Adenocarcinoma; Non-small cell lung cancer
- Focus Therapeutic Use
- 07 Dec 2016 New trial record